|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Investments at fair value | ||||||||||||||||
| Non-Control / Non-Affiliate investments | ||||||||||||||||
| Affiliate investments | ||||||||||||||||
| Control investments | ||||||||||||||||
| Total investments at fair value | ||||||||||||||||
| Cash (restricted cash of $18,349 and $12,933 as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||
| Foreign currencies (cost of $18,490 and $14,922 as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||
| Interest and fees receivable | ||||||||||||||||
| Investments funded in advance | ||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||
| Derivative assets | ||||||||||||||||
| Credit Support Agreements | ||||||||||||||||
| Foreign Exchange Contract | ||||||||||||||||
| Deferred financing fees | ||||||||||||||||
| Receivable from unsettled transactions | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities: | ||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||
| Interest payable | ||||||||||||||||
| Administrative fees payable | ||||||||||||||||
| Base management fees payable | ||||||||||||||||
| Incentive management fees payable | ||||||||||||||||
| Derivative liabilities | ||||||||||||||||
| Payable from unsettled transactions | ||||||||||||||||
| Borrowings under credit facility | ||||||||||||||||
| Notes payable (net of deferred financing fees) | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net Assets: | ||||||||||||||||
| Common stock, $0.001 par value per share (150,000,000 shares authorized, 104,706,884 shares issued and outstanding as of both June 30, 2026 and December 31, 2025) | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Total distributable earnings (loss) | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and net assets | ||||||||||||||||
| Net asset value per share (in dollars per share) |
Loading...
